We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+5.68%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$2.54B
Cap. Flow
+$1.55B
Cap. Flow %
7.41%
Top 10 Hldgs %
15.24%
Holding
2,978
New
379
Increased
824
Reduced
813
Closed
161

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$798M
2
XOM icon
ExxonMobil
XOM
+$189M
3
CTSH icon
Cognizant
CTSH
+$86.4M
4
MRK icon
Merck
MRK
+$80.6M
5
IART icon
Integra LifeSciences
IART
+$47.9M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$57.5M
2
PEP icon
PepsiCo
PEP
+$55.1M
3
DG icon
Dollar General
DG
+$49.7M
4
WOOF
VCA Inc.
WOOF
+$48.1M
5
SPG icon
Simon Property Group
SPG
+$45.6M

Sector Composition

Rank Sector Weight
1 Healthcare 17.52%
2 Technology 14.11%
3 Financials 12.07%
4 Industrials 10.58%
5 Consumer Discretionary 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NWBO
2151
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$2K ﹤0.01%
+12,150
New +$2K
XLKS
2152
DELISTED
POWERSHARES S&P SMALLCAP INFORMATION TECHNOLOGY PORTFOLIO
XLKS
$2K ﹤0.01%
+37
New +$2K
CHA
2153
DELISTED
China Telecom Corporation, LTD
CHA
$2K ﹤0.01%
55
-35
-39% -$1.67K
SMI
2154
DELISTED
Semiconductor Manufacturing Intl
SMI
$2K ﹤0.01%
+471
New +$3.24K
ABG icon
2155
Asbury Automotive
ABG
$4.19B
$1K ﹤0.01%
30
– –
AN icon
2156
AutoNation
AN
$6.97B
$1K ﹤0.01%
47
– –
ATRC icon
2157
AtriCure
ATRC
$1.77B
$1K ﹤0.01%
+85
New +$1.49K
BCRX icon
2158
BioCryst Pharmaceuticals
BCRX
$2.37B
$1K ﹤0.01%
200
– –
BSBR icon
2159
Santander
BSBR
$39.7B
$1K ﹤0.01%
230
-5,227
-96% -$51.1K
CODI icon
2160
Compass Diversified
CODI
$755M
$1K ﹤0.01%
99
– –
COHR icon
2161
Coherent
COHR
$55.2B
$1K ﹤0.01%
+45
New +$1.59K
CROX icon
2162
Crocs
CROX
$6.69B
$1K ﹤0.01%
+235
New +$1.63K
DFIN icon
2163
Donnelley Financial Solutions
DFIN
$1.21B
$1K ﹤0.01%
62
– –
EWX icon
2164
State Street SPDR S&P Emerging Markets Small Cap ETF
EWX
$662M
$1K ﹤0.01%
35
– –
FF icon
2165
Future Fuel
FF
$204M
$1K ﹤0.01%
138
– –
GGB icon
2166
Gerdau
GGB
$9.44B
$1K ﹤0.01%
383
– –
GOGL
2167
DELISTED
Golden Ocean Group
GOGL
$1K ﹤0.01%
200
– –
HEI icon
2168
HEICO Corp
HEI
$48.9B
$1K ﹤0.01%
44
– –
JAZZ icon
2169
Jazz Pharmaceuticals
JAZZ
$15.9B
$1K ﹤0.01%
13
– –
JEF icon
2170
Jefferies Financial Group
JEF
$12.9B
$1K ﹤0.01%
108
-19
-15% -$425
KGC icon
2171
Kinross Gold
KGC
$28.5B
$1K ﹤0.01%
294
– –
LAB icon
2172
Standard BioTools
LAB
$326M
$1K ﹤0.01%
+235
New +$1.49K
LILA icon
2173
Liberty Latin America Class A
LILA
$1.51B
$1K ﹤0.01%
127
-15
-11% -$223
MAC icon
2174
Macerich
MAC
$7.32B
$1K ﹤0.01%
30
– –
CALY
2175
Callaway Golf Company
CALY
$3.26B
$1K ﹤0.01%
153
+143
+1,430% +$1.56K
85 86
87
88 89

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q1 2017 Portfolio in Review

As of Q1 2017, Glenmede Trust held 2,978 positions worth $20.9B, up 14% from $18.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Glenmede Trust deployed $1.55B of net new capital in Q1 2017, opening 379 new positions and adding to 824 existing holdings. Its largest new stake was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Activision Blizzard, an estimated $57.5M trimmed.

  • Glenmede Trust's largest Q1 2017 buy was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
  • Glenmede Trust added most to Johnson & Johnson in Q1 2017, an estimated $798M increase.
  • Glenmede Trust's biggest Q1 2017 reduction was Activision Blizzard, cutting an estimated $57.5M.
  • Glenmede Trust fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $22.5M.
  • Glenmede Trust's ten largest holdings make up 15% of its $20.9B portfolio in Q1 2017.
  • Glenmede Trust opened 379 new positions and closed 161 in Q1 2017.
  • Glenmede Trust's portfolio value rose 14% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.